ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 8 filings · Latest: May 7, 2026
Adicet Bio, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IRON | OrbiMed Private Investments VIII, LP | — | Oct 20, 2025 | Proposed Sale | $89.94 | 746,171 | $67.1M | — | |
PMVP | OrbiMed Private Investments V, LP | — | Sep 10, 2025 | Proposed Sale | $1.60 | 2,283,654 | $3.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 21, 2025 | Proposed Sale | $5.56 | 132,645 | $737.5K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 15, 2025 | Proposed Sale | $6.79 | 53,293 | $361.9K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 7, 2025 | Proposed Sale | $0.433 | 259,000 | $112.1K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jun 24, 2025 | Proposed Sale | $0.3516 | 1,076,120 | $378.4K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Apr 15, 2025 | Proposed Sale | $0.383 | 787,179 | $301.5K | — | |
CMPX | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2025 | Proposed Sale | $1.59 | 3,571,428 | $5.7M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Mar 10, 2025 | Proposed Sale | $55.67 | 74,800 | $4.2M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 193,400 | $10.8M | — | |
IRON | OrbiMed Private Investments VIII, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 299,200 | $16.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jan 6, 2025 | Proposed Sale | $0.829 | 1,140,740 | $945.7K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Dec 4, 2024 | Proposed Sale | $0.89 | 2,985,518 | $2.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Sep 16, 2024 | Proposed Sale | $0.807 | 927,572 | $748.6K | — |
← Previous
Page 2 of 2